Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension

Published:2023-02 Issue:2 Volume:42 Page:173-182
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Hirsch Kellen,Nolley Stephanie,Ralph David D.,Zheng Ying,Altemeier William A.^ORCID,Rhodes Christopher J.,Morrell Nicholas W.,Wilkins Martin R.^ORCID,Leary Peter J.,Rayner Samuel G.^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference46 articles.

1. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation;Thenappan;Eur Respir J,2010

2. Haemodynamic definitions and updated clinical classification of pulmonary hypertension;Simonneau;Eur Respir J,2019

3. Features and outcomes of methamphetamine-associated pulmonary arterial hypertension;Zamanian;Am J Respir Crit Care Med,2018

4. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension;Fisher;Arthritis Rheum,2006

5. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry;Benza;Chest,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions;JHLT Open;2024-11

2. DYZY01 alleviates pulmonary hypertension via inhibiting endothelial cell pyroptosis and rescuing endothelial dysfunction;European Journal of Pharmacology;2024-09

3. Risk stratification and treatment goals in pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

4. Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management;International Journal of Molecular Sciences;2024-08-01

5. Systemic Inflammatory Response Index (SIRI) is associated with all-cause mortality and cardiovascular mortality in population with chronic kidney disease: evidence from NHANES (2001–2018);Frontiers in Immunology;2024-03-15